Jerkeman, M, Kolstad, A, Hutchings, M, Pasanen, A, Meriranta, L, Niemann, C U, Jorgensen, R R K, El-Galaly, T C C, Riise, J, Leppä, S, Christensen, J H, Wader, K F & Glimelius, I 2022, ' Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma-the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial ', Blood, vol. 140, no. Suppl. 1, 623, pp. 184–185 . https://doi.org/10.1182/blood-2022-155654